首页 › 基金 › CAXTON CORP › ALXO
CAXTON CORP 对 ALXO 的持仓历史
ALX ONCOLOGY HLDGS INC · 医疗保健
CAXTON CORP 在 Q2 2026 的 13F 申报中披露持有 ALXO(ALX ONCOLOGY HLDGS INC)20,946 股,市值约 US$43K,约占其申报组合的 2.34%,在其申报持仓中市值排名第 10 位。 CAXTON CORP 最近 2 个申报季度中有 2 个季度披露了 ALXO 持仓,最早可追溯至 Q1 2026。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
CAXTON CORP 对 ALXO 的持仓演变
CAXTON CORP 于 Q1 2026 首次披露 ALXO 持仓:20,946 股(约 US$42K)。 该持仓在 Q2 2026 达到峰值 20,946 股,市值约 US$43K。 在 2 次申报中,CAXTON CORP 的持股数量始终未变。 最近一期申报(Q2 2026)显示持股 20,946 股、市值约 US$43K。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2026 | 20.95K | $42.00K | 新进 |
| Q2 2026 | 20.95K | $43.36K | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ALXO 与 13F 数据
ALXO(ALX ONCOLOGY HLDGS INC)属于医疗保健行业。我们追踪的基金中还有 36 只申报持有 ALXO,申报仓位最大的包括:venBio Partners LLC (US$26.7M), Redmile Group, LLC (US$15.3M), SILVERARC CAPITAL MANAGEMENT, LLC (US$11.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ALXO 的基金
- venBio Partners LLC 12.88M 股 · $26.67M · Q2 2026
- Redmile Group, LLC 7.39M 股 · $15.30M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 5.74M 股 · $11.89M · Q2 2026
- TCG Crossover Management, LLC 5.66M 股 · $11.71M · Q2 2026
- Vivo Capital, LLC 3.18M 股 · $6.59M · Q2 2026
- 5AM Venture Management, LLC 3.06M 股 · $6.33M · Q2 2026
- Almitas Capital LLC 2.94M 股 · $6.08M · Q2 2026
更多关于 CAXTON CORP
常见问题
How long has CAXTON CORP held ALXO?
CAXTON CORP has disclosed ALXO holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is CAXTON CORP's current position in ALXO?
As of Q2 2026, CAXTON CORP holds 20.95K shares of ALXO (ALX ONCOLOGY HLDGS INC), valued at $43.36K, representing 2.34% of its reported portfolio and ranking #10.
Has CAXTON CORP been buying or selling ALXO?
In the latest 13F filing (Q2 2026), CAXTON CORP held unchanged its position in ALXO. The position peaked in Q2 2026 at 20.95K shares.
Which other funds hold ALXO?
Other major institutional holders of ALXO include venBio Partners LLC, Redmile Group, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.